Precigen (PGEN) Projected to Post Earnings on Wednesday

Precigen (NASDAQ:PGEN) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $1.30 million for the quarter.

Precigen Stock Performance

Shares of NASDAQ:PGEN opened at $1.78 on Tuesday. The company has a 50 day moving average price of $1.56 and a two-hundred day moving average price of $1.13. The company has a market capitalization of $521.31 million, a PE ratio of -3.24 and a beta of 1.58. Precigen has a 52 week low of $0.65 and a 52 week high of $2.17.

Analyst Ratings Changes

Several brokerages recently commented on PGEN. HC Wainwright reaffirmed a “buy” rating and set a $6.00 price objective (up previously from $4.00) on shares of Precigen in a research note on Thursday, January 23rd. JMP Securities reaffirmed a “market outperform” rating and set a $5.00 price target on shares of Precigen in a research report on Tuesday, January 14th. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Precigen currently has an average rating of “Hold” and a consensus price target of $7.00.

About Precigen

Precigen, Inc operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar.